Rezultati pretraživanja
  1. Osobe Vidi sve

  2. prije 12 sati

    Simple and public, the value of has risen so far that their compliance department requires sales. Meanwhile they buy gene editing biotech companies which are oversold. And, hey Can you show a 'lil respect for the winner?

  3. prije 14 sati

    "Apple is worth over one trillion dollars today and while they make great products, they are not curing cancer." I bought and this morning. In the next 10 years, these three companies can fundamentally improve human life expectancy and quality.

  4. prije 16 sati

    Evercore ISI downgraded to an In Line rating, $52 PT

  5. 3. velj

    Expecting huge recovery on oversold beaten down best in class and most promising Will only get higher from here if coronavirus stays relatively contained in US and outside China. and small plays in , data expected

  6. 31. sij

    On the opposite side of trade @ . Added below $52, recent stake reductions are purely short term cash needs. Expecting new set of trial data, big news of 1st patient dosing will HUGE Pop! Don't mix coronavirus, just use as opportunity. PT $75+

  7. Call/Put Highest % Volume Changes: Calls: , , , , Puts: , , , ,

  8. 31. sij
  9. 29. sij

    Long health care -telehealth platform Doctors face time is the future -tumor testing Testing get breakthrough -Gene editing The code for all cure -disposable robotics Clean and fixed form inside the body -informatics lab pediatric and rare diseases

  10. 28. sij
  11. 27. sij
  12. 27. sij

    Why are genome editing companies down on ? Isn't the main objective of genome editing to attack and disable any virus by making changes to DNA?

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.